It is a pharma private limited company based in Ahmedabad, Gujarat, India, established in 2021.
2021 | Ahmedabad, Gujarat, India | ActiveHawksbill Pharmaceuticals Private Limited, a active private limited company, was established on 05 February 2021 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24230GJ2021PTC120020. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹0.10 M and a paid-up capital of ₹75.00 K .
Its leadership includes Aahna Sinha (Director), Astha Sinha (Director), Bishwas Kumar Sinha (Director). Past directors included Aahna Sinha, Astha Sinha, Amit Jaiswal. It holds ₹2.60 M open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at B-401, Lake View Tower Opp. Vastrapur Lake, Vastrapur, Ahmedabad, Gujarat, 380015.
U24230GJ2021PTC120020
120020
05 February 2021
₹0.10 M
₹75.00 K
Roc Ahmedabad
Unlisted
Active
Explore comprehensive insights into Hawksbill Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aahna Sinha | Director | 21 Aug 2023 | Current |
| Astha Sinha | Director | 21 Aug 2023 | Current |
| Bishwas Kumar Sinha | Director | 05 Feb 2021 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2023 | Past |
| Pramod Abcsdd | Director | 01 Jun 2021 | Past |
| Pramod Abcsdd | Director | 12 Sep 2023 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Hawksbill Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 48.96% decrease. The company also saw a substantial fall in profitability, with a 49.11% decrease in profit. The company's net worth Soared by an impressive increase of 15.19%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
Unlock access to Hawksbill Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Reveal ownership structures and financial performance - Get instant access now!
₹2,600,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 Sep 2023 | Indian Overseas Bank | ₹1.80 M | Open |
| 31 Mar 2022 | Indian Overseas Bank | ₹0.80 M | Open |
Explore comprehensive loan charge details -
Hawksbill Pharmaceuticals has a workforce of 0 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Hawksbill Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Hawksbill Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on A charge with Indian Overseas Bank of Rs. 1.80 M registered on 27 Sep 2023 with Charge ID 100799541 was modified on 30 Nov 2024. was documented.
Hawksbill Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was recorded as a recent event.
The activity Hawksbill Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Ahmedabad. was completed.
The activity A charge with Indian Overseas Bank amounted to Rs. 1.80 M with Charge ID 100799541 was registered on 27 Sep 2023. was completed.
The activity Aahna Sinha was appointed as a Director was appointed as a Director on 21 Aug 2023 & has been associated with this company since 2 years 4 months . was completed.
Astha Sinha was appointed as a Director was appointed as a Director on 21 Aug 2023 & has been associated with this company since 2 years 4 months . was recorded as a recent event.
The CIN of Hawksbill Pharmaceuticals Private Limited is U24230GJ2021PTC120020.
Hawksbill Pharmaceuticals Private Limited is headquartered at B-401, Lake View Tower Opp. Vastrapur Lake, Vastrapur, Ahmedabad, Gujarat, 380015.
Hawksbill Pharmaceuticals Private Limited was incorporated on 05 February 2021.
The current directors of Hawksbill Pharmaceuticals Private Limited are
The primary industry of Hawksbill Pharmaceuticals Private Limited is Trade.
Hawksbill Pharmaceuticals Private Limited is unlisted.
The authorized capital of Hawksbill Pharmaceuticals Private Limited is ₹0.10 M, and the paid-up capital is ₹75.00 K .
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX